Digital Telepathology Market Size- By Type, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2032
Description
Digital Telepathology Market Size- By Type, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2032
Global Digital Telepathology Market Overview
According to SPER Market Research, the Global Digital Telepathology Market is estimated to reach USD 2.19 billion by 2032 with a CAGR of 9.6%. Digital telepathology, which can be used for remote primary diagnoses, quality control, second opinion consultations, research, and educational reasons, is the practice of remote pathology employing telecommunication links to permit the electronic transfer of digital pathology pictures. By enabling quick connections with experts, digital telepathology helps an increasing number of laboratories around the world provide pathology services.
Impact of COVID-19 on the Global Digital Telepathology Market
Years ago, digital pathology was created to enable pathologists to remotely work together on cases and increase the precision of diagnostic procedures by exchanging digital pictures among laboratories. Due to the US Food and Drug Administration's (FDA) and the Centers for Medicare & Medicaid Services' (CMS) stringent federal restrictions, the US fell behind the majority of developed nations in terms of adopting digital pathology prior to the COVID-19 pandemic.
Scope of the Report:
Report Metric Details
Market size available for years 2019-2032
Base year considered 2021
Forecast period 2022-2032
Segments covered By Type, By Application, By End User
Regions covered Asia-Pacific, Europe, Middle East and Africa, North America, Latin America
Companies Covered GE Healthcare, Glencoe Software, Inspirata, Kanteron Systems, Leica Biosystems, MikroSkan Technologies Inc., Olympus Corporation, OptraSCAN,
Global Digital Telepathology Market Segmentation:
By Application: Based on the Application, Global Digital Telepathology Market is segmented as; Diagnosis, Education, Research, Others.
By End User: Based on the End User, Global Digital Telepathology Market is segmented as; Academic Institutes, Diagnostic Centers and Pathology Clinics, Hospital, Pharmaceutical and Biotech Companies, Research Organizations, Others.
By Region: The largest market is in North America, where moderate growth is anticipated over the following ten years. This is brought on by a robust healthcare system, laws like the Affordable Care Act, a high incidence of different cancers, and an aging population that need medical attention.
Table of Contents
254 Pages
- 1.Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1 Research data source
- 2.1.1 Secondary data
- 2.1.2 Primary data
- 2.1.3 SPER’s internal database
- 2.1.4 Premium insight from KOL’s
- 2.2Market size estimation
- 2.2.1 Top-down and Bottom-up approach
- 2.3Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1 Drivers
- 4.1.2 Restraints
- 4.1.3 Opportunities
- 4.1.4 Challenges
- 4.2. COVID-19 Impacts of the Global Digital Telepathology Market
- 5. Market variables and outlook
- 5.1. SWOT analysis
- 5.1.1Strengths
- 5.1.2Weaknesses
- 5.1.3Opportunities
- 5.1.4Threats
- 5.2. PESTEL analysis
- 5.2.1Political landscape
- 5.2.2Economic landscape
- 5.2.3Social landscape
- 5.2.4Technological landscape
- 5.2.5Environmental landscape
- 5.2.6Legal landscape
- 5.3. PORTER’S five forces analysis
- 5.3.1Bargaining power of suppliers
- 5.3.2Bargaining power of Buyers
- 5.3.3Threat of Substitute
- 5.3.4Threat of new entrant
- 5.3.5Competitive rivalry
- 5.4. Heat map analysis
- 6.Competitive Landscape
- 6.1Global Digital Telepathology Manufacturing Base Distribution, Sales Area, Product Type
- 6.2Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Digital Telepathology Market
- 7.Global Digital Telepathology Market, By Type, 2019-2032 (USD Million)
- 7.1 Education
- 7.2 Medical
- 7.3 Other
- 8.Global Digital Telepathology Market, By Application, 2019-2032 (USD Million)
- 8.1 Diagnosis
- 8.2 Education
- 8.3 Research
- 8.4 Others
- 9.Global Digital Telepathology Market, By End User, 2019-2032 (USD Million)
- 9.1 Academic Institutes
- 9.2 Diagnostic Centers and Pathology Clinics
- 9.3 Hospital
- 9.4 Pharmaceutical and Biotech Companies
- 9.5 Research Organizations
- 9.6 Others
- 10. Global Digital Telepathology Market, By Region, 2019-2032 (USD Million)
- 10.1 Global Digital Telepathology Market and Market Share by Region (2019-2025)
- 10.2 Global Digital Telepathology Market and Market Share by Region (2026-2032)
- 10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
- 10.4 Europe
- 10.4.1 France
- 10.4.2 Germany
- 10.4.3 Italy
- 10.4.4 Spain
- 10.4.5 United Kingdom
- 10.4.6 Rest of Europe
- 10.5Middle East and Africa
- 10.5.1Kingdom of Saudi Arabia
- 10.5.2United Arab Emirates
- 10.5.3Rest of Middle East & Africa
- 10.6North America
- 10.6.1Canada
- 10.6.2Mexico
- 10.6.3United States
- 10.7Latin America
- 10.7.1Argentina
- 10.7.2Brazil
- 10.7.3Rest of Latin America
- 11. Company Profiles
- 11.1GE Healthcare
- 11.1.1Company details
- 11.1.2Financial outlook
- 11.1.3Product summary
- 11.1.4Recent developments
- 11.2Glencoe Software
- 11.2.1Company details
- 11.2.2Financial outlook
- 11.2.3Product summary
- 11.2.4Recent developments
- 11.3Inspirata
- 11.3.1Company details
- 11.3.2Financial outlook
- 11.3.3Product summary
- 11.3.4Recent developments
- 11.4Kanteron Systems
- 11.4.1Company details
- 11.4.2Financial outlook
- 11.4.3Product summary
- 11.4.4Recent developments
- 11.5Leica Biosystems
- 11.5.1Company details
- 11.5.2Financial outlook
- 11.5.3Product summary
- 11.5.4Recent developments
- 11.6MikroSkan Technologies Inc.
- 11.6.1Company details
- 11.6.2Financial outlook
- 11.6.3Product summary
- 11.6.4Recent developments
- 11.7Olympus Corporation
- 11.7.1Company details
- 11.7.2Financial outlook
- 11.7.3Product summary
- 11.7.4Recent developments
- 11.8OptraSCAN
- 11.8.1Company details
- 11.8.2Financial outlook
- 11.8.3Product summary
- 11.8.4Recent developments
- 11.9Philips Healthcare
- 11.9.1Company details
- 11.9.2Financial outlook
- 11.9.3Product summary
- 11.9.4Recent developments
- 11.10Ventana Medical Systems Inc.
- 11.10.1Company details
- 11.10.2Financial outlook
- 11.10.3Product summary
- 11.10.4Recent developments
- 12. List of Abbreviations
- 13. Reference Links
- 14. Conclusion
- 15. Research Scope
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

